Advancements in the diagnosis and treatment of renal epithelioid angiomyolipoma: A narrative review

Renal epithelioid angiomyolipoma (EAML) is a unique subtype of angiomyolipoma that contains a variety of cytoplasmic‐rich, eosinophilic cytoplasm epithelioid cells in addition to mature adipocytes, hyaline thick‐walled vessels, and smooth muscle‐like spindle cells. In recent years, increasing evidence has shown that EAML is a potentially malignant tumor. Due to the lack of typical clinical manifestations and imaging features, it is difficult to diagnose before surgery, and the diagnosis mainly depends on postoperative histopathological examination. With the advancement of pathological diagnostic techniques, more EAML cases has been discovered, but clinicians still lack a comprehensive understanding of EAML. This review comprehensively describes some pathological and clinical features of EAML, with special attention to the pathogenesis and treatment of malignant EAML in order to assist with clinical diagnosis and treatment.

[1]  S. Eggener,et al.  Clinical and pathological features of renal epithelioid angiomyolipoma (PEComa): A single institution series. , 2021, Urologic oncology.

[2]  H. Rothe,et al.  [Epithelioid angiomyolipoma of the kidney after successfully treated malignant melanoma]. , 2021, Der Urologe. Ausg. A.

[3]  P. Russo,et al.  MP39-09 GENOMIC CHARACTERIZATION OF AGGRESSIVE SPORADIC EPITHELIOID ANGIOMYOLIPOMA , 2021 .

[4]  Pengfei Wang,et al.  Clinical challenges and management of primary renal epithelioid angiomyolipoma of duplex kidney with paraneoplastic syndrome , 2021, The Journal of international medical research.

[5]  P. Argani,et al.  Cathepsin K: A Novel Diagnostic and Predictive Biomarker for Renal Tumors , 2021, Cancers.

[6]  C. Braicu,et al.  SOX11, SOX10 and MITF Gene Interaction: A Possible Diagnostic Tool in Malignant Melanoma , 2021, Life.

[7]  P. Mathevet,et al.  VEGFR Inhibitors for Uterine Metastatic Perivascular Epithelioid Tumors (PEComa) Resistant to mTOR Inhibitors. A Case Report and Review of Literature , 2021, Frontiers in Oncology.

[8]  C. Della Pepa,et al.  A rare case of spontaneous rupture of epithelioid angiomyolipoma , 2021, Urology case reports.

[9]  Huanwen Wu,et al.  Case Report: Gastrointestinal PEComa With TFE3 Rearrangement Treated With Anti-VEGFR TKI Apatinib , 2020, Frontiers in Oncology.

[10]  D. Clevert,et al.  Diagnostic Performance of Contrast-Enhanced Ultrasound (CEUS) in the Evaluation of Solid Renal Masses , 2020, Medicina.

[11]  P. Argani,et al.  Histopathologic Characterization of Bladder Perivascular Epithelioid Cell Neoplasms (PEComa) , 2020, The American journal of surgical pathology.

[12]  A. D. Dei Tos,et al.  Addition of Antiestrogen Treatment in Patients with Malignant PEComa Progressing to mTOR Inhibitors , 2020, Clinical Cancer Research.

[13]  S. Pedron,et al.  Parvalbumin immunohistochemical expression in the spectrum of perivascular epithelioid cell (PEC) lesions of the kidney , 2020, Virchows Archiv.

[14]  Ming Zhao,et al.  Malignant melanotic Xp11 neoplasms exhibit a clinicopathologic spectrum and gene expression profiling akin to alveolar soft part sarcoma: a proposal for reclassification , 2020, The Journal of pathology.

[15]  P. Rutkowski,et al.  Diagnosis and treatment of malignant PEComa tumours , 2020 .

[16]  S. Egawa,et al.  Renal angiomyolipoma with tuberous sclerosis complex: How it differs from sporadic angiomyolipoma in both management and care. , 2020, Asian journal of surgery.

[17]  Xin Li,et al.  A new management strategy for renal angiomyolipomas: superselective arterial embolization in combination with radiofrequency ablation. , 2019, Annals of translational medicine.

[18]  J. Slotta-Huspenina,et al.  Innovative ultrasound-based diagnosis of renal tumors , 2019 .

[19]  Robin L. Jones,et al.  Role of Chemotherapy, VEGFR Inhibitors, and mTOR Inhibitors in Advanced Perivascular Epithelioid Cell Tumors (PEComas) , 2019, Clinical Cancer Research.

[20]  K. Ng,et al.  Clinicopathologic analysis of renal epithelioid angiomyolipoma: Consecutively excised 23 cases , 2019, The Kaohsiung journal of medical sciences.

[21]  R. Touraine,et al.  Renal angiomyolipoma in patients with tuberous sclerosis complex: findings from the TuberOus SClerosis registry to increase disease Awareness , 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[22]  A. Gow,et al.  Immune Checkpoint Ligand PD‐L1 Is Upregulated in Pulmonary Lymphangioleiomyomatosis , 2018, American journal of respiratory cell and molecular biology.

[23]  Choung-Soo Kim,et al.  Does epithelioid angiomyolipoma have poorer prognosis, compared with classic angiomyolipoma? , 2018, Investigative and clinical urology.

[24]  M. Voss,et al.  Durable response to anti-PD-1 immunotherapy in epithelioid angiomyolipoma: a report on the successful treatment of a rare malignancy , 2018, Journal of Immunotherapy for Cancer.

[25]  E. Henske,et al.  Renal disease in tuberous sclerosis complex: pathogenesis and therapy , 2018, Nature Reviews Nephrology.

[26]  A. D. Dei Tos,et al.  Prolonged activity and toxicity of sirolimus in a patient with metastatic renal perivascular epithelioid cell tumor: a case report and literature review , 2018, Anti-cancer drugs.

[27]  K. D. Berg,et al.  Core needle biopsy clarify the histology of the small renal masses and may prevent overtreatment , 2018, International Urology and Nephrology.

[28]  Qingwei Liu,et al.  Malignant renal epithelioid angiomyolipoma with TFE3 gene amplification mimicking renal carcinoma , 2018, Clinical nephrology. Case studies.

[29]  X. Teng,et al.  RNA sequencing of Xp11 translocation-associated cancers reveals novel gene fusions and distinctive clinicopathologic correlations , 2018, Modern Pathology.

[30]  G. Freeman,et al.  TSC2-deficient tumors have evidence of T cell exhaustion and respond to anti-PD-1/anti-CTLA-4 immunotherapy. , 2018, JCI insight.

[31]  Yan Chen,et al.  Renal epithelioid angiomyolipoma: magnetic resonance imaging characteristics , 2018, Abdominal Radiology.

[32]  Shanigarn Thiravit,et al.  The different faces of renal angiomyolipomas on radiologic imaging: a pictorial review. , 2018, The British journal of radiology.

[33]  M. Hirsch,et al.  PNL2: an adjunctive biomarker for renal angiomyolipomas and perivascular epithelioid cell tumours , 2018, Histopathology.

[34]  C. Antonescu,et al.  Uterine PEComas: A Morphologic, Immunohistochemical, and Molecular Analysis of 32 Tumors , 2018, The American journal of surgical pathology.

[35]  E. Sturgis,et al.  Malignant perivascular epithelioid cell tumor of the oropharynx with strong TFE3 expression mimicking alveolar soft part sarcoma: a case report and review of the literature. , 2017, Human pathology.

[36]  Hisham Tchelepi,et al.  Applications of contrast-enhanced ultrasound in the kidney , 2018, Abdominal Radiology.

[37]  M. Guo,et al.  Challenge of FNA diagnosis of angiomyolipoma: A study of 33 cases , 2017, Cancer cytopathology.

[38]  S. Silverman,et al.  Diagnosis of Renal Angiomyolipomas: Classic, Fat-Poor, and Epithelioid Types. , 2017, Seminars in ultrasound, CT, and MR.

[39]  P. Humphrey,et al.  The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours. , 2016, European urology.

[40]  J. Reith,et al.  Malignant TFE3‐rearranged perivascular epithelioid cell neoplasm (PEComa) presenting as a subcutaneous mass , 2016, The British journal of dermatology.

[41]  S. Segal,et al.  Everolimus for renal angiomyolipoma in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis: extension of a randomized controlled trial. , 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[42]  Y. Liu,et al.  CT-imaging features of renal epithelioid angiomyolipoma , 2015, World Journal of Surgical Oncology.

[43]  Liangren Liu,et al.  A Four-Year Follow-up Study of Renal Epithelioid Angiomyolipoma: A Multi-Center Experience and Literature Review , 2015, Scientific Reports.

[44]  Ghada El Sayed Esheba,et al.  Angiomyolipoma of the kidney: clinicopathological and immunohistochemical study. , 2013, Journal of the Egyptian National Cancer Institute.

[45]  J. Cheville,et al.  Epithelioid angiomyolipoma of the kidney: pathological features and clinical outcome in a series of consecutively resected tumors , 2013, Modern Pathology.

[46]  A. Gown,et al.  Pure Epithelioid PEComas (So-Called Epithelioid Angiomyolipoma) of the Kidney: A Clinicopathologic Study of 41 Cases: Detailed Assessment of Morphology and Risk Stratification , 2011, The American journal of surgical pathology.

[47]  R. Peces,et al.  Low-dose rapamycin reduces kidney volume angiomyolipomas and prevents the loss of renal function in a patient with tuberous sclerosis complex. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[48]  J. Epstein,et al.  Renal Epithelioid Angiomyolipoma With Atypia: A Series of 40 Cases With Emphasis on Clinicopathologic Prognostic Indicators of Malignancy , 2010, The American journal of surgical pathology.

[49]  C. Magi-Galluzzi,et al.  Renal Angiomyolipoma: Clinicopathologic Study of 194 Cases With Emphasis on the Epithelioid Histology and Tuberous Sclerosis Association , 2009, The American journal of surgical pathology.

[50]  C. Pan,et al.  Constant allelic alteration on chromosome 16p (TSC2 gene) in perivascular epithelioid cell tumour (PEComa): genetic evidence for the relationship of PEComa with angiomyolipoma , 2008, The Journal of pathology.

[51]  A. Gown,et al.  Renal angiomyolipoma: further immunophenotypic characterization of an expanding morphologic spectrum. , 2001, Archives of pathology & laboratory medicine.

[52]  A. Folpe,et al.  Immunohistochemical Study of Microphthalmia Transcription Factor and Tyrosinase in Angiomyolipoma of the Kidney, Renal Cell Carcinoma, and Renal and Retroperitoneal Sarcomas: Comparative Evaluation With Traditional Diagnostic Markers , 2001, The American journal of surgical pathology.

[53]  G. Zamboni,et al.  Renal angiomyolipoma with epithelioid sarcomatous transformation and metastases: demonstration of the same genetic defects in the primary and metastatic lesions. , 2000, The American journal of surgical pathology.

[54]  G. Zamboni,et al.  Perivascular epithelioid cell. , 1996, The American journal of surgical pathology.